Prognostic significance of RelB overexpression in non-small cell lung cancer patients

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Autophagy-induced RelB/p52 activation mediates tumour-associated macrophage repolarisation and suppression of hepatocellular carcinoma by natural compound baicalin

(2015) H-Y Tan et al.   Cell Death & Disease

RelB: an outlier in leukocyte biology

(2013) Patrick Millet et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The NF-κB RelB Protein Is an Oncogenic Driver of Mesenchymal Glioma

(2013) Dong Whan Lee et al.   PLoS One

Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival

(2012) S. M. Ranuncolo et al.   BLOOD

The RelB subunit of NFκB acts as a negative regulator of circadian gene expression

(2012) Marina M. Bellet et al.   CELL CYCLE

NF- B, the first quarter-century: remarkable progress and outstanding questions

(2012) M. S. Hayden et al.   GENES & DEVELOPMENT

NF-κB and the link between inflammation and cancer

(2012) Joseph A. DiDonato et al.   IMMUNOLOGICAL REVIEWS

NSCLC and the alternative pathway of NF-κB: uncovering an unknown relation

(2012) Fotinos-Ioannis D. Dimitrakopoulos et al.   VIRCHOWS ARCHIV

Lung-Targeted Overexpression of the NF-κB Member RelB Inhibits Cigarette Smoke–Induced Inflammation

(2011) David H. McMillan et al.   AMERICAN JOURNAL OF PATHOLOGY

Interaction of aryl hydrocarbon receptor and NF-κB subunit RelB in breast cancer is associated with interleukin-8 overexpression

(2011) Christoph Franz Adam Vogel et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

(2011) William D. Travis et al.   Journal of Thoracic Oncology

Classical and/or alternative NF- B pathway activation in multiple myeloma

(2010) Y. N. Demchenko et al.   BLOOD

Regulation and Function of NF-κB Transcription Factors in the Immune System

(2009) Sivakumar Vallabhapurapu et al.   Annual Review of Immunology

RelB Enhances Prostate Cancer Growth: Implications for the Role of the Nuclear Factor- B Alternative Pathway in Tumorigenicity

(2009) Y. Xu et al.   CANCER RESEARCH

Inhibition of RelB by 1,25-dihydroxyvitamin D3promotes sensitivity of breast cancer cells to radiation

(2009) Nora D. Mineva et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Lack of nuclear factor- B2/p100 causes a RelB-dependent block in early B lymphopoiesis

(2008) F. Guo et al.   BLOOD